🧴
Widespread Itch (Pruritus) — Systematic Assessment Excluding primary skin disease · Identifying systemic causes · NICE/CKS-aligned pathway
Progress 0 / 9
The full reasoning pathway — decide whether the itch is with or without a primary rash; itch without a rash mandates a systemic and malignancy screen. Classify the cause, refer, treat, and safety-net.StartDecisionInvestigateActionReferStop / Admit
PresentationGeneralised pruritus
With or without a rash? Duration, distribution, systemic symptoms, drugs. Examine skin, nodes, organomegaly.
Step 1 · Safety — systemic red flagsSystemic red flags?
Itch + weight loss/night sweats/lymphadenopathy → lymphoma. Jaundice (cholestasis). Severe with systemic illness.
YES
Stop · EscalateInvestigate / escalate
Suspected lymphoma → urgent haematology pathway; cholestatic → investigate liver.
NO
AssessBy pattern
Morphology, distribution and history localise the cause.
Step 3 · common causes
With primary rash
Dermatological
Eczema, scabies, urticaria, lichen planus, dermatitis herpetiformis; treat cause + emollients.
Without rash — systemic
Screen broadly
FBC, ferritin, U&E, LFT, TFT, glucose, bilirubin; iron deficiency, CKD, liver, thyroid, polycythaemia.
Drug / senile
Common
Opioids, senile xerosis; emollients, review drugs.
ReferEscalation
2WW NICE NG12 itch + lymphadenopathy/weight loss/night sweats → suspected haematological cancer. Dermatology unexplained or refractory pruritus.
Step 8 · treat cause & skin care
Step 8 · Treat the cause & skin careSymptom relief alongside cause-hunting
Liberal emollients + soap substitutes; avoid hot baths, overheating, harsh soaps and rough fabrics; keep nails short, cool the skin. Treat the driver — iron/thyroid/renal/liver disease, scabies (treat the household). Sedating antihistamine at night for sleep; review opioids and other culprit drugs. Manage the scratch-itch cycle.
Step 9 · review & safety-net
Step 9 · Review & safety-netRecheck & when to escalate
Review the systemic screen and response to treatment; recheck if itch persists despite skin care. Urgent if B-symptoms (weight loss, night sweats, lymphadenopathy → lymphoma) or new jaundice (cholestasis) develop. Persistent itch without a rash warrants repeating/broadening the bloods rather than continued symptomatic treatment alone.
⚠️ Generalised itch without a rash is a systemic symptom: screen for iron deficiency, renal, liver, thyroid and haematological disease — and consider lymphoma when B-symptoms accompany it.
1
Safety

Red Flags — Exclude Sinister Causes First

Screen immediately for haematological malignancy, solid organ cancer, and advanced systemic disease before attributing itch to benign causes.

Drenching night sweats + weight loss Pruritus + B-symptoms → Same-day bloods + urgent haematology (lymphoma, leukaemia)
Palpable lymphadenopathy Cervical/axillary/inguinal nodes + itch → 2WW haematology referral (Hodgkin's lymphoma classically causes severe itch)
Jaundice Yellow sclera/skin + pruritus → Same-day LFTs + bilirubin (cholestatic liver disease, biliary obstruction, pancreatic cancer)
Polycythaemia features Facial plethora, aquagenic itch (worse after hot shower), headache, visual disturbance → FBC same-day (polycythaemia vera)
Uraemic features Known CKD + severe itch, nausea, confusion → eGFR, U&Es same-day (uraemic pruritus — dialysis threshold)
Cholestasis of pregnancy Pruritus in 2nd/3rd trimester, especially palms/soles at night → Same-day LFTs + bile acids (risk of stillbirth)
Unexplained weight loss >5% + itch → 2WW CT chest/abdomen/pelvis (occult malignancy)
Generalised itch + iron deficiency without anaemia or obvious source → 2WW upper GI endoscopy (GI malignancy)
Generalised pruritus without visible primary skin lesion (pruritus sine materia) is a paraneoplastic phenomenon in up to 30% of Hodgkin's lymphoma cases — the itch may precede lymphoma diagnosis by months. Aquagenic pruritus is pathognomonic for polycythaemia vera in 40–50% of cases. Intrahepatic cholestasis of pregnancy carries a 1–2% stillbirth risk if bile acids exceed 40 µmol/L — early detection is critical. Missing these diagnoses in a 10-minute appointment has serious medico-legal consequences.
2
Diagnose

Characterise the Itch — History Tool

Use a structured history to distinguish dermatological from systemic causes before examining. The history drives the investigation strategy.

Onset & duration
Acute (<6 weeks) vs chronic (>6 weeks). Sudden onset suggests drug reaction or contact allergen. Gradual onset suggests systemic cause.
Distribution
Generalised = likely systemic. Localised = likely dermatological. Palms/soles nocturnal = cholestasis of pregnancy. Perianal/genital = threadworm, lichen sclerosus.
Timing
Nocturnal: scabies, uraemia, cholestasis. Post-hot shower (aquagenic): polycythaemia vera. Seasonal: dry skin (winter itch), atopic flares.
Associated skin changes
Primary rash present → dermatological cause. No rash (pruritus sine materia) → systemic cause more likely. Excoriations only = not diagnostic.
Drug history
Full drug review including OTC, herbal. Common culprits: opioids, ACE inhibitors, diuretics, statins, calcium channel blockers, allopurinol.
Systemic symptoms
Weight loss, fatigue, night sweats, thirst, polyuria, jaundice, dyspnoea — any positive → investigate for systemic disease.
Contact history
New soap, detergent, cosmetics, jewellery (nickel), occupation exposure, pet contact.
Family/household
Others affected → scabies (highly contagious), contact dermatitis from shared products.
The pattern of itch is highly diagnostic: aquagenic itch is 90% specific for polycythaemia vera when combined with erythrocytosis. Nocturnal itch affecting multiple household members is scabies until proven otherwise — prescribing without diagnosing leads to treatment failure and ongoing transmission. Drug-induced pruritus accounts for up to 5% of chronic itch referrals and is fully reversible on withdrawal.
3
Diagnose

Classify Cause — Dermatological vs Systemic vs Neuropathic vs Psychogenic

The International Forum on the Study of Itch (IFSI) classifies chronic pruritus into categories that guide investigation and treatment.

Category 1
Dermatological
Primary skin lesion present. Eczema, psoriasis, urticaria, lichen planus, scabies, tinea. Manage the underlying skin condition. Most common category in GP.
Category 2
Systemic
No primary skin lesion. Causes: hepatic (cholestasis, PBC, PSC), renal (CKD, uraemia), haematological (polycythaemia vera, lymphoma, iron deficiency), endocrine (thyroid disease, diabetes), drug-induced.
Category 3
Neurological
Neuropathic itch: brachioradial pruritus (UV-induced, cervical spine), postherpetic itch, small fibre neuropathy. Often burning/stinging quality. Responds to gabapentinoids not antihistamines.
Category 4
Psychogenic
Diagnosis of exclusion. Associated with anxiety, depression, OCD (compulsive scratching), delusional parasitosis. Often accompanies other psychological symptoms.
Category 5
Mixed
Multiple simultaneous causes (e.g., eczema + CKD + drug). Common in elderly. Address each component.
Chronic pruritus
Duration >6 weeks. Requires systematic investigation. Do not attribute to dry skin alone without excluding systemic cause.
Classification prevents therapeutic nihilism — antihistamines are only modestly effective in IgE-mediated conditions (urticaria, atopic eczema) and are largely ineffective for systemic, neuropathic, or cholestatic pruritus. Misclassification leads to years of inadequate treatment. Elderly patients often have mixed-category itch with xerosis, polypharmacy, and CKD contributing simultaneously.
4
Diagnose

Targeted Examination

Full skin examination is mandatory. Systemic examination directed by history findings.

Full skin exam
Entire body surface including scalp, genitalia, interdigital spaces, axillae. Look for: primary lesions (papules, vesicles, urticaria), burrows (scabies — especially web spaces, wrists, belt line), excoriations, secondary changes (lichenification, prurigo nodularis).
Dermographism
Stroke skin firmly — immediate whealing = symptomatic dermographism (commonest cause of physical urticaria). Positive in 5% population
Lymph nodes
Cervical, axillary, inguinal, epitrochlear. Firm, non-tender, rubbery nodes → 2WW haematology Lymphoma/CLL
Abdomen
Hepatomegaly, splenomegaly (haematological malignancy, portal hypertension), ascites (chronic liver disease).
Jaundice assessment
Scleral icterus, skin colour, spider naevi, palmar erythema, leukonychia → liver disease.
Thyroid
Goitre, thyroid eye disease signs → thyroid dysfunction (both hypo- and hyperthyroidism can cause pruritus).
Nails
Leukonychia (hypoalbuminaemia), koilonychia (iron deficiency), nail changes in psoriasis, lichen planus.
Neurological screen
If brachioradial pruritus suspected: ice pack test (cooling relieves neuropathic itch), dermatomal distribution, check cervical spine range of movement.
Scabies burrows in web spaces are pathognomonic but easily missed — misdiagnosis as eczema leads to years of inappropriate treatment and ongoing community transmission. Splenomegaly in the context of pruritus has a high positive predictive value for haematological malignancy or polycythaemia vera and mandates urgent investigation. Prurigo nodularis (hyperkeratotic nodules on extensor surfaces from chronic scratching) is a clinical diagnosis that signals long-standing undertreated itch requiring specialist input.
5
Diagnose

Investigations — Systematic Screen

For pruritus without primary skin lesion (>6 weeks), investigate systematically. Do not skip the screen even if a skin cause seems likely in an elderly patient.

First-line bloods
All patients
FBC (polycythaemia, eosinophilia, anaemia, lymphocytosis) · LFTs (cholestasis, hepatitis) · Renal function/eGFR · TFTs · Fasting glucose/HbA1c · Ferritin (iron deficiency without anaemia causes itch) · ESR/CRP · Calcium
Directed second-line
ANA/ANCA (autoimmune) · SPEP (myeloma) · HIV test · Coeliac serology (IgA tTG) · Hepatitis B and C serology · Bile acids (if pregnant or cholestasis suspected) · AMA/ANA (PBC if alkaline phosphatase elevated)
Pregnancy
LFTs + serum bile acids if 2nd/3rd trimester — bile acids >40 µmol/L = high risk → same-day obstetric referral
Imaging
CXR: mediastinal lymphadenopathy (lymphoma). Abdominal USS: hepatic/biliary pathology, splenomegaly. CT chest/abdomen/pelvis: if B-symptoms, weight loss, or lymphadenopathy.
Skin scraping
If scabies suspected: dermoscopy (visualise burrows/mites) or skin scraping sent for microscopy. Clinical diagnosis usually sufficient for treatment
When NOT to investigate
Do NOT order full screen for acute itch (<6 weeks) with clear dermatological cause (e.g., acute urticaria, contact dermatitis). Treat and review.
Iron deficiency without anaemia is an under-recognised cause of itch — ferritin <15 µg/L causes pruritus via effects on epidermal nerve fibre density. In one study, 6% of patients with unexplained pruritus had undiagnosed lymphoma. Eosinophilia >1.5 × 10⁹/L warrants urgent haematology referral (hypereosinophilic syndrome). A structured investigation screen has a diagnostic yield of approximately 25% in chronic idiopathic pruritus.
6
Refer

Referral Criteria — When Specialist Input Is Needed

Most dermatological causes can be managed in primary care. Systemic causes and treatment-refractory cases need specialist input.

Same-day
Cholestasis of pregnancy with bile acids >40 µmol/L → obstetrics · Uraemic crisis (eGFR <15, symptoms of uraemia) → nephrology · B-symptoms + lymphadenopathy → haematology
2WW
Suspected lymphoma (lymphadenopathy + pruritus + B-symptoms) → haematology · Unexplained weight loss + pruritus → CT-guided 2WW · Polycythaemia vera (Hb >185 M/>165 F + aquagenic itch) → haematology · NICE NG12: pruritus with splenomegaly/lymphadenopathy → suspected haematological cancer referral
Urgent routine (2–4 weeks)
Abnormal LFTs with cholestatic pattern → hepatology/gastroenterology · Suspected PBC (raised ALP + AMA positive) → hepatology · Prurigo nodularis (secondary to chronic itch) → dermatology
Routine dermatology
Itch failing 3 months of primary care treatment · Diagnostic uncertainty · Suspected cutaneous T-cell lymphoma (mycosis fungoides — present as pruritic patches/plaques) · Suspected brachioradial pruritus
Routine other
Refractory uraemic pruritus → nephrology (for dialysis optimisation or naltrexone) · Psychological itch, delusional parasitosis → liaison psychiatry · CKD-associated itch with eGFR 15–45 → nephrology for difelikefalin consideration
Mycosis fungoides (cutaneous T-cell lymphoma) can masquerade as eczema or psoriasis for years — the clue is itch out of proportion to skin findings and poor response to standard treatments. Early dermatology referral is critical. Difelikefalin (a kappa-opioid receptor agonist) was approved in 2022 for haemodialysis-associated pruritus with 70% response rate — a significant advance requiring nephrology prescribing.
7
Treat

Treatment Pathway — Stepwise Approach by Cause

Treat the underlying cause first. Symptomatic antipruritic therapy alongside, not instead of, cause-directed treatment.

Scabies
Permethrin 5% cream First-line
Apply neck downwards, including under nails, leave 8–12 hours, wash off. Repeat after 7 days. Treat ALL household contacts simultaneously. Wash clothing/bedding at 60°C.
Dry skin / xerosis
Emollient therapy First-line
Emollient 500g/week as soap substitute + moisturiser (e.g., Doublebase, Epaderm) twice daily minimum. Add topical crotamiton 10% cream if symptomatic relief needed.
Urticaria
Non-sedating antihistamine First-line
Cetirizine 10 mg OD or loratadine 10 mg OD. If inadequate: up to 4× licensed dose (off-label). Add montelukast 10 mg OD if refractory. Avoid triggers.
Cholestatic pruritus
Colestyramine 4–8g/day First-line
4g sachet before breakfast. Separate other medications by 1–4 hours. Second-line: rifampicin 150–300mg BD (monitor LFTs). Third-line: naltrexone 12.5–50mg OD.
Iron deficiency
Ferrous sulfate 200mg BD Treat deficiency
Continue for 3 months after ferritin normalises. Pruritus typically resolves within 4–6 weeks of treatment.
Neuropathic itch
Gabapentin 300mg OD–TDS First-line neuropathic
Start 300mg nocte, titrate up. Alternative: pregabalin 75mg BD. Capsaicin 0.025–0.075% cream for localised neuropathic itch. Antihistamines ineffective.

Symptomatic relief (all causes):
Step 1Emollients + cooling — Cool compresses, menthol 0.5–2% in aqueous cream. Keep nails short. Cotton clothing. Avoid hot baths.
Step 2Sedating antihistamine at night — Chlorphenamine 4mg nocte (short-term, avoid in elderly). Hydroxyzine 25mg nocte — better evidence for pruritus than other antihistamines.
Step 3Topical corticosteroid — Only if inflammatory skin component present. Hydrocortisone 1% for mild/face. Betamethasone 0.1% for lichenified areas. Do NOT use on normal skin.
Step 4Specialist options — Naltrexone 12.5–50mg OD (opioid antagonist — effective across multiple pruritus types) · Mirtazapine 7.5–15mg nocte (H1 + 5-HT2 antagonism — useful for malignancy-related itch) · Aprepitant (NK1 antagonist) · Dupilumab (if atopic eczema refractory)
Sedating antihistamines have poor evidence for non-histaminergic pruritus (the majority of systemic causes) — their benefit is sedation, not antipruritic action. Hydroxyzine has evidence as a true antipruritic (H1 + 5-HT antagonism). Mirtazapine 7.5–15mg nocte is particularly effective in cancer-related pruritus with NNT approximately 3.5. Naltrexone works by blocking endogenous opioid-mediated itch signalling — effective in cholestatic, uraemic, and malignancy-related pruritus. In scabies, failing to treat all household members simultaneously guarantees treatment failure and re-infestation within 6 weeks.
8
Lifestyle

Non-Pharmacological Interventions — Essential Alongside Drug Treatment

Lifestyle modifications reduce itch intensity significantly and are often as effective as antihistamines. Prescribe them explicitly.

Skin hydration Apply emollient within 3 minutes of bathing. Use soap substitute. Reduces transepidermal water loss by 40–50%, directly reducing itch stimulus.
Cool bathing Lukewarm water (not hot). Hot water causes mast cell degranulation and histamine release — dramatically worsens all itch types. Reduces itch by 30–40%.
Nail care Keep fingernails cut short and clean. Reduces skin damage from scratching and secondary bacterial infection risk.
Clothing choice Loose, cotton clothing against skin. Avoid wool, synthetic fabrics. Cotton mittens at night if nocturnal scratching. Reduces mechanical itch triggers.
Temperature control Cool bedroom (<18°C). Avoid overheating. Sweating exacerbates most itch conditions. Ceiling fans reduce nocturnal itch.
Stress management Psychological stress activates itch pathways via CRH/NK1 receptor activation. CBT reduces itch intensity scores by 30–40%. Refer to psychological therapies if appropriate.
Alcohol avoidance Alcohol causes vasodilation and pruritus flares in urticaria, eczema, psoriasis, and rosacea. Abstinence during flares recommended.
Diet review Identify and avoid triggers (pseudoallergens, food additives in chronic urticaria). Elimination diet supervised by dietitian if food triggers suspected.
The scratch-itch cycle is self-perpetuating: scratching causes keratinocyte damage, releasing cytokines (IL-31, IL-33, TSLP) that amplify itch signalling. Physical barriers (mittens, nail cutting) break this cycle. Cool water activates TRPM8 (cold receptor) channels in sensory neurons, directly inhibiting TRPV1-mediated itch signals — this is why cooling relieves itch of all causes. Emollient therapy alone reduces itch intensity by a mean of 35% in xerotic pruritus in the elderly.
9
Safety

Follow-Up, Monitoring & Safety-Netting

Chronic pruritus requires systematic review. Many systemic causes evolve — a normal initial screen does not preclude future malignancy or organ disease.

2 weeks
Scabies treatment review: confirm household contacts treated, check for treatment failure (new burrows after 2nd application → consider oral ivermectin 200 mcg/kg single dose — off-label in UK, specialist prescription).
4–6 weeks
Symptomatic response to treatment: if iron deficiency treated, check itch resolution. If drug cause identified and stopped, confirm resolution. Adjust antihistamine dose if needed.
3 months
Chronic pruritus review: repeat FBC, LFTs, eGFR if initial screen was borderline. Check for new systemic symptoms. If no improvement → reassess diagnosis, consider referral.
6 months
If no cause found despite full investigation: repeat screen at 6 months. Malignancy and haematological disease can present with isolated pruritus months before other features emerge.
Safety-net — same day
New lymphadenopathy · Jaundice · Significant weight loss · Fever + night sweats · Aquagenic itch + headache/visual disturbance (polycythaemia)
Safety-net — 999
Anaphylaxis (urticaria + angio-oedema + dysphagia/dyspnoea/hypotension) → IM adrenaline 0.5mg, 999
Pregnancy special
Review bile acids every 1–2 weeks if cholestasis of pregnancy diagnosed. Bile acids >100 µmol/L → consider early delivery with obstetrics.
In a longitudinal study of chronic pruritus, 10% of patients with initial negative investigations were diagnosed with a systemic condition within 5 years. The most common late diagnoses were haematological malignancy, autoimmune liver disease, and occult carcinoma. The 6-month repeat screen is therefore not optional. Oral ivermectin (unlicensed) has 95% efficacy for crusted/Norwegian scabies and permethrin-resistant scabies — a single specialist-directed course resolves what years of permethrin failed to treat.
Educational use only. Pathway based on NICE CKS Pruritus (2023), IFSI Classification of Chronic Pruritus, BTS/SIGN guidelines, RCGP curriculum. Always adapt to individual patient context, co-morbidities, and local formulary.